About 9,260 results
Open links in new tab
  1. Home - Wockhardt

    Wockhardt Global School, Aurangabad, is a not-for-profit initiative dedicated to developing a student community of lifelong learners that imbibes skills, knowledge and values required for …

  2. About Us - Wockhardt

    Team Wockhardt Corporate Milestones Research & Development R&D at Wockhardt New Drug Discovery Pipeline / Projects News & Events

  3. Our Business Verticals - Wockhardt

    Wockhardt is a fully integrated, innovation-led company committed to provide high quality biological products at an affordable price for needy patients and healthcare systems across …

  4. Board of Directors - Wockhardt

    Dr. Habil Khorakiwala founded Wockhardt in 1967. Today, the Wockhardt Group is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, …

  5. Contact us - Wockhardt

    To report an adverse event about a Wockhardt product in India, please contact us at: 1800 258 8127 (Monday to Friday, 9AM to 5PM IST) Note: We are closed on Saturday, Sunday and …

  6. Chairman's Profile - Wockhardt

    Today, the Wockhardt Group is India’s leading research-based, global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology, Active Pharmaceutical Ingredients …

  7. Corporate Milestones - Wockhardt

    1967 Wockhardt founded by Dr. Habil Khorakiwala 1972 Launch of PROXYVON - the first combination formulation in pain management 1979

  8. News & Events - Wockhardt

    28 Jun 2024 Wockhardt claims breakthrough in drug-resistant infection in cancer patients with experimental drug Zaynich; US body awards highest susceptibility to the antibiotic

  9. New Drug Discovery - Wockhardt

    Realizing this challenge, Wockhardt discovery team embarked on identifying a novel oral respiratory antibiotic with coverage of multi-drug resistant pathogens, assuring safety profile …

  10. Pipeline/Projects - Wockhardt

    Pipeline/Projects Discovery Projects Owing to the sustained and focused efforts, our antibiotic discovery team has been able to evolve a rich pipeline of candidate drugs which are either …